Limiting the use and misuse of liothyronine in hypothyroidism
- 24 October 2024
- journal article
- editorial
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 21 (1) , 3-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Medically not yet explained symptoms in hypothyroidismNature Reviews Endocrinology, 2024
- Optimizing the treatment of hypothyroidismNature Reviews Endocrinology, 2024
- Hypothyroidism and Type D Personality: Results From E-MPATHY, a Cross-sectional International Online Patient SurveyThe Journal of Clinical Endocrinology & Metabolism, 2024
- Hypothyroidism and Somatization: Results from E-Mode Patient Self-Assessment of Thyroid Therapy, a Cross-Sectional, International Online Patient SurveyThyroid®, 2023
- Critical Approach to Hypothyroid Patients With Persistent SymptomsThe Journal of Clinical Endocrinology & Metabolism, 2023
- Heart Failure and Stroke Risks in Users of Liothyronine With or Without Levothyroxine Compared with Levothyroxine Alone: A Propensity Score-Matched AnalysisThyroid®, 2022
- Enhanced Well-Being Associated with Thyrotoxicosis: A Neglected Effect of Thyroid Hormones?International Journal of Endocrinology and Metabolism, 2022
- Primary hypothyroidism and quality of lifeNature Reviews Endocrinology, 2022
- Neither Baseline nor Changes in Serum Triiodothyronine during Levothyroxine/Liothyronine Combination Therapy Predict a Positive Response to This Treatment Modality in Hypothyroid Patients with Persistent SymptomsEuropean Thyroid Journal, 2017
- Treating Hypothyroidism with Thyroxine/Triiodothyronine Combination Therapy in Denmark: Following Guidelines or Following Trends?European Thyroid Journal, 2015